EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
51 hedge funds and large institutions have $6.08M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$488K | |
| 2 | +$21.5K | |
| 3 | +$9.52K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$5.55K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$2.59K |
Top Sellers
| 1 | -$336K | |
| 2 | -$147K | |
| 3 | -$114K | |
| 4 |
Renaissance Technologies
New York
|
-$50K |
| 5 |
JPMorgan Chase & Co
New York
|
-$41.3K |